Seminars in Respiratory and Critical Care Medicine

Issue 02 · Volume 43 · April 2022 DOI: 10.1055/s-012-53337 HAP and VAP after Guidelines Guest Editors: Ignacio Martin-Loeches, MD, and Antoni Torres, MD

Preface

173

Martin-Loeches, Ignacio; Torres, Antoni:

Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia after Guidelines

Review Article

175

Abouelhassan, Yasmeen P.; Nicolau, David:

Pharmacokinetic/Pharmacodynamic Optimization of Hospital-Acquired and Ventilator-Associated Pneumonia: Challenges and Strategies

183

Pan, Di; Niederman, Michael S.:

Risk Factors and Algorithms for the Empirical Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

191

Lynch, Joseph P.; Zhanel, George G.:

Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy

219

Renaud, Cherie; Kollef, Marin H.:

Classical and Molecular Techniques to Diagnose HAP/VAP

229

Ceccato, Adrian; Torres, Antoni:

Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia

234

Chen, Fangyue; Qasir, Danyal; Morris, Andrew Conway:

Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias

243

Rouzé, Anahita; Nseir, Saad:

Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19

248

Wicky, Paul-Henri; Martin-Loeches, Ignacio; Timsit, Jean-François:

HAP and VAP after Guidelines

255

Boisson, Matthieu; Bouglé, Adrien; Sole-Lleonart, Candela; Dhanani, Jayesh; Arvaniti, Kostoula; Rello, Jordi; Rouby, Jean-Jacques; Mimoz, Olivier; On Behalf of the European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP):